InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Huang James, Director. Director active across 3 companies, notably Ziopharm Oncology INC. Aggregated, 9 disclosures have been logged. Total volume traded: €452k. The latest transaction was disclosed on 22 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
080,000 shares0
Common Stock
SEC:0000899243-22-024006:0·
080,000 shares0
Common Stock
SEC:0000899243-22-023988:0·
05,000 shares0
Common Stock
SEC:0001437749-22-014716:0·
€81,78850,000 shares@ €1.6358100.0% of flow
Common Stock
SEC:0001437749-21-023912·
Ideal exit: 16 Jul 2022 (T+270)
€81,78850,000 shares@ €1.635814.27% mcap50.0% of flow
Common Stock
SEC:0001437749-21-023912:0·
Ideal exit: 16 Jul 2022 (T+270)
€144,415100,000 shares@ €1.4441100.0% of flow
Common Stock
SEC:0001209191-21-054824·
Ideal exit: 29 May 2022 (T+270)
€144,415100,000 shares@ €1.444150.0% of flow
Common Stock
SEC:0001209191-21-054824:0·
Ideal exit: 29 May 2022 (T+270)
8,333 shares
Common Stock
SEC:0001209191-21-030740·
08,333 shares0
Common Stock
SEC:0001209191-21-030740:0·
9 of 9 declarations
About Huang James
James Huang is a Director at ZIOPHARM Oncology Inc, Windtree Therapeutics Inc, and Alaunos Therapeutics, Inc. In this role, he participates in the governance of the companies and in strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions.
